Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1982 Jan;47(1):206–216.

Deleted IgG1 and IgG2 H chains in a patient with an IgG subclass imbalance.

J P Lebreton, M Fontaine, J Rousseaux, P Youinou, D Hurez, L Rivat-Peran, J P Bernards
PMCID: PMC1536352  PMID: 6807588

Abstract

The serum of a female patient studied over 7 months initially showed, in addition to normal residual IgG, two abnormal IgG proteins and in the last 3 months of the disease showed only one abnormal IgG protein. Gm typing and serological subclass determinations revealed an imbalance of allelic forms within the IgG1 subclass during the disease. The IgG2 level remained markedly elevated throughout the study. The two abnormal IgG-related proteins were devoid of light chains. The abnormal gamma cathodic immunoglobulin and the abnormal beta 2-immunoglobulin were Fc-like and covalently disulphide linked, with molecular weights of 60,000 daltons (N terminal, SER) and 72,000 daltons (N terminal, GLY) respectively. The first belonged to the IgG1 subclass and the second to the IgG2 subclass. No abnormal proteolytic activity was noted and plasma cells reacted with anti-gamma-chain antisera only. We hypothesize that the molecular defect leading to the deleted chains was an early event, preceding the differentiation into plasma cells which produced the two IgG1 and IgG2 deleted H chains.

Full text

PDF
206

Images in this article

209Fig. 1
on p.209
211Fig. 2
on p.211
212Fig. 3
on p.212
212Fig. 4
on p.212
213Fig. 5
on p.213

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adlersberg J. B., Grann V., Zucker-Franklin D., Frangione B., Franklin E. C. An unusual case of a plasma cell neoplasm with an IgG3lambda myeloma and a gamma3 heavy chain disease protein. Blood. 1978 Jan;51(1):85–96. [PubMed] [Google Scholar]
  2. BACHMANN R. SIMULTANEOUS OCCURRENCE OF TWO IMMUNOLOGICALLY DIFFERENT M-COMPONENTS IN SERUM. Acta Med Scand. 1965 May;177:593–599. doi: 10.1111/j.0954-6820.1965.tb01868.x. [DOI] [PubMed] [Google Scholar]
  3. Bihrer R., Flury R., Morell A. Biklonale Paraproteinämie. Schweiz Med Wochenschr. 1974 Jan 12;104(2):39–45. [PubMed] [Google Scholar]
  4. Bouvet J. P., Feingold J., Oriol R., Liacopoulos P. Statistical study on double paraproteinemias. Evidence for a common cellular origin of both myeloma globulins. Biomedicine. 1975 Nov;22(6):517–523. [PubMed] [Google Scholar]
  5. Burton R. M., Deutsch H. F. The structure of peptides of Fc-fragments from gamma G-globulins of known allotypic specificity. Immunochemistry. 1970 Feb;7(2):145–156. doi: 10.1016/0019-2791(70)90150-3. [DOI] [PubMed] [Google Scholar]
  6. Cornwell G. G., 3rd, Michaelsen T. E., Sanders W. H. Comparative studies of a monoclonal IgG lambda and two IgE kappa components from an individual patient: evidence for shared idiotypic determinants between the two IgE proteins but not with the IgG lambda protein. Immunology. 1980 Apr;39(4):511–517. [PMC free article] [PubMed] [Google Scholar]
  7. Fair D. S., Krueger R. G., Gleich G. J., Kyle R. A. Studies on IgA and IgG monoclonal proteins derived from a single patient. I. Evidence for shared individually specific antigenic determinants. J Immunol. 1974 Jan;112(1):201–209. [PubMed] [Google Scholar]
  8. Fair D. S., Schaffer S., Krueger R. G. Development of monoclonal IgA and an apparent IgG in a patient with macroglobulinemia: sharing of individually specific antigenic determinants among IgM, IgA, and IgG. J Immunol. 1976 Sep;117(3):944–949. [PubMed] [Google Scholar]
  9. Frangione B., Franklin E. C., Fudenberg H. H., Koshland M. E. Structural studies of human gamma-G-myeloma proteins of different antigenic subgroups and genetic specificities. J Exp Med. 1966 Oct 1;124(4):715–732. doi: 10.1084/jem.124.4.715. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Frangione B., Milstein C., Franklin E. C. Chemical typing of immunoglobulins. Nature. 1969 Jan 11;221(5176):149–151. doi: 10.1038/221149a0. [DOI] [PubMed] [Google Scholar]
  11. Franklin E. C., Kyle R., Seligmann M., Frangione B. Correlation of protein structure and immunoglobulin gene organization in the light of two new deleted heavy chain disease proteins. Mol Immunol. 1979 Nov;16(11):919–921. doi: 10.1016/0161-5890(79)90090-7. [DOI] [PubMed] [Google Scholar]
  12. Franklin E. C., Prelli F., Frangione B. Human heavy chain disease protein WIS: implications for the organization of immunoglobulin genes. Proc Natl Acad Sci U S A. 1979 Jan;76(1):452–456. doi: 10.1073/pnas.76.1.452. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Franklin E. C. Some impacts of clinical investigation on immunology. Surface IgD, IgE, and heavy-chain variants. N Engl J Med. 1976 Mar 4;294(10):531–537. doi: 10.1056/NEJM197603042941006. [DOI] [PubMed] [Google Scholar]
  14. GRAY W. R., HARTLEY B. S. THE STRUCTURE OF A CHYMOTRYPTIC PEPTIDE FROM PSEUDOMONAS CYTOCHROME C-551. Biochem J. 1963 Nov;89:379–380. doi: 10.1042/bj0890379. [DOI] [PubMed] [Google Scholar]
  15. Gold E. R., Fudenberg H. H. Chromic chloride: a coupling reagent for passive hemagglutination reactions. J Immunol. 1967 Nov;99(5):859–866. [PubMed] [Google Scholar]
  16. Gore M. E., Riches P. G., Kohn J. Identification of the paraproteins and clinical significance of more than one paraprotein and clinical significance of more than one paraprotein in serum of 56 patients. J Clin Pathol. 1979 Apr;32(4):313–317. doi: 10.1136/jcp.32.4.313. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Gros C., Labouesse B. Study of the dansylation reaction of amino acids, peptides and proteins. Eur J Biochem. 1969 Feb;7(4):463–470. doi: 10.1111/j.1432-1033.1969.tb19632.x. [DOI] [PubMed] [Google Scholar]
  18. Isobe T., Osserman E. F. Plasma cell dyscrasia associated with the production of incomplete (?deleted) IgGlambda molecules, gamma heavy chains, and free lambda chains containing carbohydrate: description of the first case. Blood. 1974 Apr;43(4):505–526. [PubMed] [Google Scholar]
  19. Josephson A. S., Nicastri A., Price E., Biro L. H chain fragment and monoclonal IgA in a lymphoproliferative disorder. Am J Med. 1973 Jan;54(1):127–135. doi: 10.1016/0002-9343(73)90091-0. [DOI] [PubMed] [Google Scholar]
  20. Keller H., Spengler G. A., Skvaril F., Flury W., Noseda G., Riva G. Zur Frage der Heavy chain disease. Ein Fall von IgG-heavy-chain-Fragment- und IgM-Typ K-Paraproteinämie mit Plasmazellenleukämie. Schweiz Med Wochenschr. 1970 Jun 13;100(24):1012–1022. [PubMed] [Google Scholar]
  21. Krueger R. G., Hilton P. M., Boehlecke J. M., Kyle R. A., Fair D. S. The cellular origin of multiple monoclonal immunoglobulins reflects the postulated pathways of isotype differentiation of antibody-forming cells. Cell Immunol. 1980 Sep 1;54(2):402–413. doi: 10.1016/0008-8749(80)90220-8. [DOI] [PubMed] [Google Scholar]
  22. Kunkel H. G., Yount W. J., Litwin S. D. Genetically determined antigen of the Ne subgroup of gamma-globulin: detection by precipitin analysis. Science. 1966 Nov 25;154(3752):1041–1043. doi: 10.1126/science.154.3752.1041. [DOI] [PubMed] [Google Scholar]
  23. Lebreton J. P., Joisel F., Raoult J. P., Lannuzel B., Rogez J. P., Humbert G. Serum concentration of human alpha 2 HS glycoprotein during the inflammatory process: evidence that alpha 2 HS glycoprotein is a negative acute-phase reactant. J Clin Invest. 1979 Oct;64(4):1118–1129. doi: 10.1172/JCI109551. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Liebow A. A., Carrington C. B. Diffuse pulmonary lymphoreticular infiltrations associated with dysproteinemia. Med Clin North Am. 1973 May;57(3):809–843. doi: 10.1016/s0025-7125(16)32278-7. [DOI] [PubMed] [Google Scholar]
  25. Mancini G., Carbonara A. O., Heremans J. F. Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry. 1965 Sep;2(3):235–254. doi: 10.1016/0019-2791(65)90004-2. [DOI] [PubMed] [Google Scholar]
  26. Natvig J. B., Turner M. W. Localization of Gm markers to different molecular regions of the Fc fragment. Clin Exp Immunol. 1971 May;8(5):685–700. [PMC free article] [PubMed] [Google Scholar]
  27. Oriol R., Huerta J., Bouvet J. P., Liacopoulos P. Two myeloma globulins, IgG1-kappa and IgG1-lambda, from a single patient (Im). I. Purification and immunochemical characterization. Immunology. 1974 Dec;27(6):1081–1093. [PMC free article] [PubMed] [Google Scholar]
  28. PORTER R. R. The hydrolysis of rabbit y-globulin and antibodies with crystalline papain. Biochem J. 1959 Sep;73:119–126. doi: 10.1042/bj0730119. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Penn G. M., Kunkel H. G., Grey H. M. Sharing of individual antigenic determinants between a gamma G and a gamma M protein in the same myeloma serum. Proc Soc Exp Biol Med. 1970 Dec;135(3):660–665. doi: 10.3181/00379727-135-35116. [DOI] [PubMed] [Google Scholar]
  30. Press E. M., Hogg N. M. The amino acid sequences of the Fd fragments of two human gamma-1 heavy chains. Biochem J. 1970 May;117(4):641–660. doi: 10.1042/bj1170641. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Rivat L., Rivat C., Lebreton J. P., Ropartz C. Antigenic determinants of heavy chain variable regions: immumological typing of the human immunoglobulin VHIII subgroup. Eur J Immunol. 1976 Sep;6(9):624–629. doi: 10.1002/eji.1830060906. [DOI] [PubMed] [Google Scholar]
  32. Rudders R. A., Yakulis V., Heller P. Double myeloma. Production of both IgG type lambda and IgA type lambda myeloma proteins by a single plasma cell line. Am J Med. 1973 Aug;55(2):215–221. doi: 10.1016/0002-9343(73)90171-x. [DOI] [PubMed] [Google Scholar]
  33. SCHEIDEGGER J. J. Une micro-méthode de l'immuno-electrophorèse. Int Arch Allergy Appl Immunol. 1955;7(2):103–110. [PubMed] [Google Scholar]
  34. Sakano H., Rogers J. H., Hüppi K., Brack C., Traunecker A., Maki R., Wall R., Tonegawa S. Domains and the hinge region of an immunoglobulin heavy chain are encoded in separate DNA segments. Nature. 1979 Feb 22;277(5698):627–633. doi: 10.1038/277627a0. [DOI] [PubMed] [Google Scholar]
  35. Sarasombath S., Mestecky J., Skvaril F. Monoclonal IgG3-kappa and IgG1-lambda proteins with different idiotypic determinants present in a single patient. Clin Exp Immunol. 1977 Jul;29(1):67–74. [PMC free article] [PubMed] [Google Scholar]
  36. Scolari L., Vaerman J. P., Castigli E., Voliani D., Salsano F., Masala C., Di Guglielmo R. Late appearance of an IgA (kappa) monoclonal protein in a patient with IgG (kappa) multiple myeloma: sharing of idiotypic specificities between the two serum proteins. Scand J Immunol. 1978;8(3):201–206. doi: 10.1111/j.1365-3083.1978.tb00511.x. [DOI] [PubMed] [Google Scholar]
  37. Spengler G. A., Steinberg A. G., Skvaril F. Development of a second monoclonal immunoglobulin G in a patient with late manifestation of myeloma. Acta Med Scand. 1972 Oct;192(4):309–314. doi: 10.1111/j.0954-6820.1972.tb04820.x. [DOI] [PubMed] [Google Scholar]
  38. Virella G., Monteiro J. M., Lopes-Virella M. F., Ducla Soares A., Fudenberg H. H. Asynchronous development of two monoclonal proteins (IgM lambda and delta 1 chains) in a patient with abdominal lymphoma. Cancer. 1977 May;39(5):2247–2253. doi: 10.1002/1097-0142(197705)39:5<2247::aid-cncr2820390543>3.0.co;2-1. [DOI] [PubMed] [Google Scholar]
  39. Wang A. C., Wilson K. S., Hopper J. E., Fudenberg H. H., Nisonoff A. Evidence for control of synthesis of the varible regions of the heavy chains of immunoglobulins G and M by the same gene. Proc Natl Acad Sci U S A. 1970 Jun;66(2):337–343. doi: 10.1073/pnas.66.2.337. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Weber K., Osborn M. The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis. J Biol Chem. 1969 Aug 25;244(16):4406–4412. [PubMed] [Google Scholar]
  41. Wolfenstein-Todel C., Franklin E. C., Rudders R. A. Similarities of the light chains and the variable regions of the heavy chains of the IgG2 lambda and IgA1 lambda myeloma proteins from a single patient. J Immunol. 1974 Mar;112(3):871–876. [PubMed] [Google Scholar]
  42. Yagi Y., Pressman D. Monoclonal IgA and IgM in the serum of a single patient (SC). I. Sharing of individually specific determinants between IgA and IgM. J Immunol. 1973 Feb;110(2):335–344. [PubMed] [Google Scholar]
  43. van Camp B. G., Shuit H. R., Hijmans W., Radl J. The cellular basis of double paraproteinemia in man. Clin Immunol Immunopathol. 1978 Jan;9(1):111–119. doi: 10.1016/0090-1229(78)90127-7. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES